Special Collection: Transcranial ultrasound stimulation and its applications in the neurosciences. Our latest guest-edited collection brings together recent research published in BMC Neuroscience concerning technological advances, potential applications, and therapeutic effects, of transcranial ultrasound stimulation.
Featured article: Exercise challenge alters Default Mode Network dynamics in Gulf War Illness
Exercise-induced deactivation patterns within the Default Mode Network may have novel biomarker potential in Gulf War Illness.
Aims and scope
BMC Neuroscience is an open access, peer-reviewed journal that considers articles on all aspects of the nervous system, including molecular, cellular, developmental and animal model studies, as well as cognitive and behavioral research, and computational modeling.
Editor
- Samuel Harris, BioMed Central
Manuscript Editor
- Darren Byrne, BioMed Central
Assistant Editor
- Brock Madsen, BioMed Central
Section Editors
- Jiu-Lin Du, Shanghai Institute of Neuroscience, Chinese Academy of Sciences
- Robert Gerlai, University of Toronto Mississauga
- Tianzi Jiang, Institute of Automation, Chinese Academy of Sciences
- Anthony Kline, University of Pittsburgh
- Thomas Munte, University of Luebeck
- Maurizio Popoli, University of Milan
- Mark Rasenick, University of Illinois, Chicago
- Vijayalakshmi Ravindranath, Indian Institute of Science
- Karsten Ruscher, University of Lund
- Shanbao Tong, Jiao Tong University
- Si Wu, Beijing normal University
Data Support Services pilot
Authors submitting to this journal can opt to use a new service that will make it easier to share research data.
Mark Rasenick, Section Editor
Mark M. Rasenick, Ph.D.
Distinguished Professor of Physiology & Biophysics and Psychiatry
University of Illinois Chicago, College of Medicine and Research Service, Jesse Brown VAMC
Dr. Rasenick’s work has focused on G protein signaling in the nervous system. He has been particularly interested in how G proteins and the cytoskeleton work in concert to modify synaptic shape and to form a molecular basis for depression and the action of antidepressant drugs. He is also founder of Pax Neuroscience, a company designed to develop and utilize depression biomarkers for diagnostics, treatment and drug development. He is an elected fellow of the American College of Neuropsychopharmacology and the American Association for the Advancement of Science and the Cuban Academy of Sciences.
In addition to research and teaching, Dr. Rasenick is active in public policy. He currently chairs the Advocacy Committee for the American Brain Coalition. While a Robert Wood Johnson Fellow (1999-2000), he was a staff member with the late Senator Edward M. Kennedy, (D Mass.). He is also involved in international outreach for neuroscience.
BMC Series blog
Advertisement
Follow
2017 Journal Metrics
-
Citation Impact
2.173 - 2-year Impact Factor
2.756 - 5-year Impact Factor
0.780 - Source Normalized Impact per Paper (SNIP)
1.120 - SCImago Journal Rank (SJR)Usage
888,726 Downloads
382 Altmetric Mentions
Advertisement
